Wedbush Securities’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$463K Sell
5,578
-1,099
-16% -$91.2K 0.02% 661
2025
Q1
$542K Buy
6,677
+95
+1% +$7.71K 0.02% 585
2024
Q4
$593K Buy
6,582
+405
+7% +$36.5K 0.02% 554
2024
Q3
$610K Sell
6,177
-162
-3% -$16K 0.02% 528
2024
Q2
$588K Sell
6,339
-1,576
-20% -$146K 0.02% 573
2024
Q1
$751K Buy
7,915
+2,514
+47% +$239K 0.03% 490
2023
Q4
$482K Sell
5,401
-809
-13% -$72.2K 0.02% 563
2023
Q3
$453K Sell
6,210
-5,098
-45% -$372K 0.02% 561
2023
Q2
$941K Sell
11,308
-1,285
-10% -$107K 0.04% 336
2023
Q1
$960K Sell
12,593
-3,281
-21% -$250K 0.05% 328
2022
Q4
$1.32M Sell
15,874
-5,488
-26% -$456K 0.07% 233
2022
Q3
$1.69M Buy
21,362
+9,257
+76% +$734K 0.1% 168
2022
Q2
$899K Sell
12,105
-2,140
-15% -$159K 0.05% 320
2022
Q1
$1.28M Sell
14,245
-1,081
-7% -$97.1K 0.06% 281
2021
Q4
$1.72M Buy
15,326
+1,343
+10% +$150K 0.07% 217
2021
Q3
$1.76M Buy
13,983
+742
+6% +$93.3K 0.08% 209
2021
Q2
$1.79M Buy
13,241
+185
+1% +$25.1K 0.08% 211
2021
Q1
$1.77M Buy
13,056
+3,103
+31% +$421K 0.1% 184
2020
Q4
$1.4M Sell
9,953
-4,300
-30% -$605K 0.12% 179
2020
Q3
$1.59M Buy
14,253
+3,158
+28% +$352K 0.15% 143
2020
Q2
$1.24M Buy
11,095
+1,125
+11% +$126K 0.12% 176
2020
Q1
$772K Sell
9,970
-344
-3% -$26.6K 0.09% 239
2019
Q4
$981K Sell
10,314
-209
-2% -$19.9K 0.09% 255
2019
Q3
$802K Sell
10,523
-372
-3% -$28.4K 0.08% 287
2019
Q2
$956K Sell
10,895
-887
-8% -$77.8K 0.1% 241
2019
Q1
$1.07M Buy
11,782
+7,810
+197% +$707K 0.11% 211
2018
Q4
$285K Buy
+3,972
New +$285K 0.04% 556
2017
Q4
Sell
-7,807
Closed -$676K 906
2017
Q3
$676K Buy
7,807
+2,589
+50% +$224K 0.09% 269
2017
Q2
$403K Buy
+5,218
New +$403K 0.05% 449
2015
Q2
Sell
-4,803
Closed -$361K 776
2015
Q1
$361K Buy
+4,803
New +$361K 0.06% 367
2013
Q4
Sell
-11,265
Closed -$485K 618
2013
Q3
$485K Buy
11,265
+1,638
+17% +$70.5K 0.13% 192
2013
Q2
$335K Buy
+9,627
New +$335K 0.09% 266